EMvision Director Increases Stake with On-Market Share Purchase

EMvision Medical Devices Ltd. ( (AU:EMV) ) has shared an announcement.

EMvision Medical Devices has reported a change in director Carmel Monaghan’s holdings, following an on-market purchase of additional equity in the company. Monaghan acquired 10,000 ordinary shares on 22 April 2026 for a total consideration of $18,470, adding to her existing 200,000 unlisted options exercisable at $3.00 and expiring on 31 December 2028.

The transaction increases the director’s direct stake in EMvision and may be read by investors as a signal of confidence in the company’s prospects. The company confirmed that the trade did not occur during a closed period requiring prior written clearance, indicating adherence to its trading and governance policies.

The most recent analyst rating on (AU:EMV) stock is a Buy with a A$3.15 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.

More about EMvision Medical Devices Ltd.

EMvision Medical Devices Ltd is an Australian-listed medical technology company focused on developing and commercialising medical devices. Its activities center on healthcare applications, with securities traded on the ASX and governance overseen by a board that includes director Carmel Monaghan.

Average Trading Volume: 45,631

Technical Sentiment Signal: Buy

Current Market Cap: A$166.8M

For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.